PBH vs AMZN

For growth investors, Amazon.

com, Inc. (AMZN) is the stronger pick with 12. 4% revenue growth year-over-year, versus 1. 1% for Prestige Consumer Healthcare Inc. (PBH). Prestige Consumer Healthcare Inc. (PBH) offers the better valuation at 13. 0x trailing P/E (12. 0x forward), making it the more compelling value choice. Analysts rate Prestige Consumer Healthcare Inc. (PBH) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Prestige Consumer Healthcare Inc.

(PBH) is the cheapest at 13. 0x versus Amazon. com, Inc. at 38. 1x. On forward P/E, Prestige Consumer Healthcare Inc. is actually cheaper at 12. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Amazon. com, Inc. wins at 1. 26x versus Prestige Consumer Healthcare Inc. 's 1. 32x — a reasonable growth-adjusted valuation.

Over the past 5 years, Amazon.

com, Inc. (AMZN) delivered a total return of +67. 3%, compared to +25. 7% for Prestige Consumer Healthcare Inc. (PBH). Over 10 years, the gap is even starker: AMZN returned +715. 9% versus PBH's -3. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Prestige Consumer Healthcare Inc.

(PBH) is the lower-risk stock at 0. 53β versus Amazon. com, Inc. 's 1. 51β — meaning AMZN is approximately 182% more volatile than PBH relative to the S&P 500. On balance sheet safety, Amazon. com, Inc. (AMZN) carries a lower debt/equity ratio of 37% versus 57% for Prestige Consumer Healthcare Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Amazon.

com, Inc. (AMZN) is pulling ahead at 12. 4% versus 1. 1% for Prestige Consumer Healthcare Inc. (PBH). On earnings-per-share growth, the picture is similar: Amazon. com, Inc. grew EPS 29. 7% year-over-year, compared to 2. 9% for Prestige Consumer Healthcare Inc.. Over a 3-year CAGR, AMZN leads at 11. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Prestige Consumer Healthcare Inc.

(PBH) is the more profitable company, earning 18. 9% net margin versus 10. 8% for Amazon. com, Inc. — meaning it keeps 18. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PBH leads at 29. 6% versus 11. 2% for AMZN. At the gross margin level — before operating expenses — PBH leads at 55. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Amazon. com, Inc. (AMZN) is the more undervalued stock at a PEG of 1. 26x versus Prestige Consumer Healthcare Inc. 's 1. 32x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Prestige Consumer Healthcare Inc. (PBH) trades at 12. 0x forward P/E versus 35. 3x for Amazon. com, Inc. — 23. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PBH: 18. 4% to $66. 00.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Prestige Consumer Healthcare Inc.

(PBH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 53)). Amazon. com, Inc. (AMZN) carries a higher beta of 1. 51 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PBH: -3. 4%, AMZN: +715. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (PBH (Healthcare) and AMZN (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: PBH is a small-cap deep-value stock; AMZN is a mega-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.